Evidence map›Paper›PMID 30397183›Full record

ArticleThe Journal of biological chemistry2018

β-Cell mass restoration by α7 nicotinic acetylcholine receptor activation.

Dhananjay Gupta, Adam A Lacayo, Shane M Greene, John L Leahy, Thomas L Jetton

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. DiabetesOmic: A comprehensive multi-omics diabetes database.Computational and structural biotechnology journal · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Nicotine Activating αMolecular neurobiology · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dhananjay GuptaFrom the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont 05446.
Adam A LacayoFrom the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont 05446.
Shane M GreeneFrom the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont 05446.
John L LeahyFrom the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont 05446.
Thomas L JettonFrom the Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont 05446. Electronic address: tjetton@uvm.edu.
University of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although it is well-established how nutrients, growth factors, and hormones impact functional β-cell mass (BCM), the influence of the central nervous system in this regard, and especially in the context of islet immune modulation, has been understudied. Here we investigated the expression and activity of pancreatic islet α7 nicotinic acetylcholine receptor (α7nAChR) in islet anti-inflammatory and prosurvival signaling. Systemic administration of α7nAChR agonists in mice improved glucose tolerance and curtailed streptozotocin-induced hyperglycemia by retaining BCM, in part through maintaining Pdx1 and MafA expression and reducing apoptosis. α7nAChR activation of mouse islets

Indexed as

Signal Transductionalpha7 Nicotinic Acetylcholine ReceptorAnimalsCell Line, TumorCell SurvivalCyclic AMP Response Element-Binding ProteinHyperglycemiaInsulin Receptor Substrate ProteinsInsulin-Secreting CellsMaleMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktStreptozocinalpha7 Nicotinic Acetylcholine ReceptorCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinInsulin Receptor Substrate ProteinsIrs2 protein, mousePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktStreptozocinautoimmune diseasebeta cell (β-cell)cholinergic receptordiabetesion channelisletnicotinic acetylcholine receptors (nAChR)pancreatic isletSTAT3

Identifiers

PMID30397183
PMCPMC6311516
OpenAlexW2899970519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.